Canada’s CGPA Installs New Leaders
Appoints New Chair And Vice-Chair From Pharmascience And Apotex
Executive Summary
Canada’s off-patent industry association has looked to Pharmascience and Apotex for its new chair and vice-chair.
You may also be interested in...
Canada Must Learn ‘Difficult Lessons’ From COVID-19
Canadian policymakers must learn “difficult lessons” from the coronavirus pandemic and support measures to bolster domestic production and secure the country’s position as part of the global supply chain, according to CGPA president Jim Keon.
Aspen Expects Growth Following Sandoz And Viatris Deals
Aspen expects to report significant growth in its continuing operations for the first half of its financial year, following deals with Sandoz and Viatris that have seen the South African firm divest major businesses in Japan and Europe.
Three Pillars Must Support Value Added Medicines In EU
Medicines for Europe has called for fresh efforts to bolster the value added medicines sector and “level the playing field” with the US and its 505(b)(2) pathway, launching a new report setting out the three key areas in which greater EU action is needed.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: